@ARTICLE{
author={Bergh Florian Then|,Singer BA|,Drulovic Jelena S|0000-0002-4516-3458,Bidollari I|,Chen Hailu|,Englishby R|,Hanna Jerome|,Kandinov Boris|,Lopez-Bresnahan Maria|,Leigh-Pemberton Richard|,Miller Catherine|,Mokliatchouk O|,Shafer SJ|},
year={2019},
title={Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={25},
number={},
pages={861-862},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Arnold Douglas L|,LaGanke Christopher|,Obradovic Dragana V|,Gudesblatt Mark|,Yang Lili|,Miller Catherine|,Leigh-Pemberton Richard|,Lopez-Bresnahan Maria|,Kandinov Boris|,Wolinsky Jerry S|},
year={2019},
title={Diroximel Fumarate (DRF) in Patients With Relapsing-Remitting Multiple Sclerosis: Interim Efficacy and Safety Results From the Phase 3 EVOLVE-MS-1 Study},
journal={NEUROLOGY},
volume={92},
number={15},
pages={-},
document_type={Meeting Abstract},
}